Epiyangambin [CAS 24192-64-1]

Epiyangambin is a competitive platelet activating factor receptor (PAF) antagonist that dose-dependently inhibits PAF-induced platelet aggregation. Epiyangambin also inhibits the growth of human colon cancer cells (SW480 cells) [1][2].

[24192-64-1]

C24H30O8

446.49

COC1=C(OC)C(OC)=CC([C@H]2OC[C@]3([H])[C@H](C4=CC(OC)=C(OC)C(OC)=C4)OC[C@@]32[H])=C1

Platelet-activating Factor Receptor (PAFR)

10 mM in DMSO

Room temperature

H315-H319-H335

P261-P264-P271-P280-P302+P352-P304+P340-P362+P364-P405-P501